Pzena Investment Management increased its Avnet ring (AVT); LIVING CELL TECHNOLOGIES LTD ORDINARY SH (LVCLF) sellers reduced their shorts by 37.5%



<! –

Stock news

->

September 2, 2018 – From Ricky Cave

Avnet, Inc.'s logo (NASDAQ: AVT)

Pzena Investment Management Llc increased the participation of Avnet Inc (AVT) by 1.66% reported in 2018Q1 SEC filings. Pzena Investment Management Llc acquired 149,923 shares, while the share of Avnet Inc (AVT) decreased by 10.23%. Pzena Investment Management Llc has shares of 9.18 million with a value of $ 383.42 million, up from 9.03 million in the last quarter. Avnet Inc now has a value of $ 5.60 billion. The shares fell by 0.64% or $ 0.31 to $ 48.4 during the last trading session. Approximately 1.13 million shares traded or 18.40% higher than the average. Avnet, Inc. (NYSE: AVT) has increased by 4.99% since 2 September 2017 and is on the rise. It performed 7.5% less well than the S & P500. Some historical AVT news: 16/05/2018 – Avnet closes below 200-day moving average: Technicals; 30/05/2018 – Consolidated study: 2018 Summary Expectations for Crown Castle International, Avnet, computer programs & # 39; s, and Model N, Century; 14/05/2018 – Avnet shows connected ecosystem at IoT World 2018; 23/05/2018 – Avnet appoints Oleg Khaykin to his board of directors; 26/04/2018 – Avnet Inc 3Q Adj EPS $ 1.02; 26/04/2018 – Avnet Inc 3Q Loss / Shr $ 2.64; 24/04/2018 – Avnet Journal unveils keys for hardening the IoT-connected supply chain; 22/05/2018 – AVNET STATES REGULARLY QTRLY DIV $ 0.19 / SHR TO PAY JUNE 19; 17/04/2018 – Avnet closes above 50-day moving average: Technicals; 02/04/2018 – Avnet Inc. CDS broadens 8 Bps

LIVING CELL TECHNOLOGIES LTD ORDINARY SH (OTCMKTS: LVCLF) decreased by 37.5% in short-term interest rates. The SI of LVCLF amounted to 5,000 shares in September as released by FINRA. It fell by 37.5% compared to 8,000 shares. With 2,600 avg. Volume, 2 days are destined for the sellers of LIVING CELL TECHNOLOGIES LTD SHORT (OTCMKTS: LVCLF) live products to cover LVCLF short positions. The lock closed at $ 0.0194. It is 0.00% since 2 September 2017 and is. It performed less well with 12.57% of the S & P500.

Pzena Investment Management Llc reduced the importance of Cisco Systems Inc (NASDAQ: CSCO) with 144,324 shares to 2.72 million, valued at $ 116.86 million in 2018Q1. It also reduced the participation of Trimas Corp (NASDAQ: TRS) with 35,746 shares and now holds 2.32M shares. Chart Industries Inc is also reduced.

Of the 5 analysts who cover Avnet (NYSE: AVT), 2 have the ratings Buy, 2 Sell and 1 Hold. That is why 40% is positive. Avnet had 7 analyst reports since April 25, 2018 according to SRatingsIntel. On Friday, June 22, the share rating was tracked by Pivotal Research at "Buy". The company has given the rating "Neutral" on Wednesday, April 25 by Bank of America. Pivotal Research has Avnet, Inc. (NASDAQ: AVT) on Friday, June 15 upgraded to the & # 39; Buy & # 39 ;. The company has a & # 39; Sell & # 39; -rating from Goldman Sachs on Wednesday, May 16th. On the shares of Avnet, Inc. (NASDAQ: AVT) state & # 39; Sell ​​& # 39; -rating awarded by Citigroup on Thursday 9 August. Bank of America has upgraded the stock to "Buy" rating in the Friday August 10 report.

Another recent and important news from Avnet, Inc. (NASDAQ: AVT) was published by Seekingalpha.com, which published an article entitled "Avnet (AVT) Q4 2018 results – Earnings Call Transcript" on August 9, 2018.

Investor sentiment fell to 0.97 in Q1 2018. It decreased by 0.19, from 1.16 in 2017Q4. It declined, as 29 investors sold AVT shares while 115 had fewer holdings. 50 funds opened positions while 89 made higher bets. 113.40 million shares or 2.48% more of 110.65 million shares in 2017Q4 were reported. Bluemountain Cap Ltd Liability Corp has invested 0.15% in Avnet, Inc. (NASDAQ: AVT). Barrow Hanley Mewhinney and Strauss Limited Liability Corporation reported 0% of the portfolio in Avnet, Inc. (NASDAQ: AVT). Alpha Windward Limited Co. has purchased 0.33% or 12,857 shares. Bokf Na reported 13,752 shares. New York State Teachers Retirement Systems, a New York fund, reported 192,348 shares. Comerica Commercial Bank, a fund in Michigan, reported 349,418 shares. 865 are owned by Ledyard Bancshares. Ameritas Inv has 0.07% of its portfolio in Avnet, Inc. (NASDAQ: AVT) for 35,696 shares. Whittier Trust has invested 0% of its portfolio in Avnet, Inc. (NASDAQ: AVT). State Board of Administration of Florida Retirement Sys reported a 0.02% interest. New Mexico Educational Retirement Board reported 0.05% to Avnet, Inc. (NASDAQ: AVT). 550 are held by Meeder Asset Mgmt. Lpl Finance Ltd Llc has invested in 0% or in 7 886 shares. Brandywine Invest Mgmt reported 460,146 shares. Lombard Odier Asset (Switzerland) Sa owns 19,380 shares.

Living Cell Technologies Limited, a biotechnology company, discovers, develops and commercializes regenerative treatments that use naturally occurring cells to restore function in New Zealand. The company has a market capitalization of $ 10.37 million. The company's main product is NTCELL, a capsule with alginate coating, which is part of Phase IIb clinical trial for the treatment of Parkinson's disease. It currently has a negative result. It has a research collaboration agreement with the Center for Brain Research at the University of Auckland to identify additional neurodegenerative disease targets for clinical trials with NTCELL.

Avnet, Inc. (NASDAQ: AVT) Diagram of institutional positions


Source link

Pzena Investment Management increased its Avnet ring (AVT); LIVING CELL TECHNOLOGIES LTD ORDINARY SH (LVCLF) sellers reduced their shorts by 37.5%



<! –

Stock news

->

September 2, 2018 – From Ricky Cave

Avnet, Inc.'s logo (NASDAQ: AVT)

Pzena Investment Management Llc increased the participation of Avnet Inc (AVT) by 1.66% reported in 2018Q1 SEC filings. Pzena Investment Management Llc acquired 149,923 shares, while the share of Avnet Inc (AVT) decreased by 10.23%. Pzena Investment Management Llc has shares of 9.18 million with a value of $ 383.42 million, up from 9.03 million in the last quarter. Avnet Inc now has a value of $ 5.60 billion. The shares fell by 0.64% or $ 0.31 to $ 48.4 during the last trading session. Approximately 1.13 million shares traded or 18.40% higher than the average. Avnet, Inc. (NYSE: AVT) has increased by 4.99% since 2 September 2017 and is on the rise. It performed 7.5% less well than the S & P500. Some historical AVT news: 16/05/2018 – Avnet closes below 200-day moving average: Technicals; 30/05/2018 – Consolidated study: 2018 Summary Expectations for Crown Castle International, Avnet, computer programs & # 39; s, and Model N, Century; 14/05/2018 – Avnet shows connected ecosystem at IoT World 2018; 23/05/2018 – Avnet appoints Oleg Khaykin to his board of directors; 26/04/2018 – Avnet Inc 3Q Adj EPS $ 1.02; 26/04/2018 – Avnet Inc 3Q Loss / Shr $ 2.64; 24/04/2018 – Avnet Journal unveils keys for hardening the IoT-connected supply chain; 22/05/2018 – AVNET STATES REGULARLY QTRLY DIV $ 0.19 / SHR TO PAY JUNE 19; 17/04/2018 – Avnet closes above 50-day moving average: Technicals; 02/04/2018 – Avnet Inc. CDS broadens 8 Bps

LIVING CELL TECHNOLOGIES LTD ORDINARY SH (OTCMKTS: LVCLF) decreased by 37.5% in short-term interest rates. The SI of LVCLF amounted to 5,000 shares in September as released by FINRA. It fell by 37.5% compared to 8,000 shares. With 2,600 avg. Volume, 2 days are destined for the sellers of LIVING CELL TECHNOLOGIES LTD SHORT (OTCMKTS: LVCLF) live products to cover LVCLF short positions. The lock closed at $ 0.0194. It is 0.00% since 2 September 2017 and is. It performed less well with 12.57% of the S & P500.

Pzena Investment Management Llc reduced the importance of Cisco Systems Inc (NASDAQ: CSCO) with 144,324 shares to 2.72 million, valued at $ 116.86 million in 2018Q1. It also reduced the participation of Trimas Corp (NASDAQ: TRS) with 35,746 shares and now holds 2.32M shares. Chart Industries Inc is also reduced.

Of the 5 analysts who cover Avnet (NYSE: AVT), 2 have the ratings Buy, 2 Sell and 1 Hold. That is why 40% is positive. Avnet had 7 analyst reports since April 25, 2018 according to SRatingsIntel. On Friday, June 22, the share rating was tracked by Pivotal Research at "Buy". The company has given the rating "Neutral" on Wednesday, April 25 by Bank of America. Pivotal Research has Avnet, Inc. (NASDAQ: AVT) on Friday, June 15 upgraded to the & # 39; Buy & # 39 ;. The company has a & # 39; Sell & # 39; -rating from Goldman Sachs on Wednesday, May 16th. On the shares of Avnet, Inc. (NASDAQ: AVT) state & # 39; Sell ​​& # 39; -rating awarded by Citigroup on Thursday 9 August. Bank of America has upgraded the stock to "Buy" rating in the Friday August 10 report.

Another recent and important news from Avnet, Inc. (NASDAQ: AVT) was published by Seekingalpha.com, which published an article entitled "Avnet (AVT) Q4 2018 results – Earnings Call Transcript" on August 9, 2018.

Investor sentiment fell to 0.97 in Q1 2018. It decreased by 0.19, from 1.16 in 2017Q4. It declined, as 29 investors sold AVT shares while 115 had fewer holdings. 50 funds opened positions while 89 made higher bets. 113.40 million shares or 2.48% more of 110.65 million shares in 2017Q4 were reported. Bluemountain Cap Ltd Liability Corp has invested 0.15% in Avnet, Inc. (NASDAQ: AVT). Barrow Hanley Mewhinney and Strauss Limited Liability Corporation reported 0% of the portfolio in Avnet, Inc. (NASDAQ: AVT). Alpha Windward Limited Co. has purchased 0.33% or 12,857 shares. Bokf Na reported 13,752 shares. New York State Teachers Retirement Systems, a New York fund, reported 192,348 shares. Comerica Commercial Bank, a fund in Michigan, reported 349,418 shares. 865 are owned by Ledyard Bancshares. Ameritas Inv has 0.07% of its portfolio in Avnet, Inc. (NASDAQ: AVT) for 35,696 shares. Whittier Trust has invested 0% of its portfolio in Avnet, Inc. (NASDAQ: AVT). State Board of Administration of Florida Retirement Sys reported a 0.02% interest. New Mexico Educational Retirement Board reported 0.05% to Avnet, Inc. (NASDAQ: AVT). 550 are held by Meeder Asset Mgmt. Lpl Finance Ltd Llc has invested in 0% or in 7 886 shares. Brandywine Invest Mgmt reported 460,146 shares. Lombard Odier Asset (Switzerland) Sa owns 19,380 shares.

Living Cell Technologies Limited, a biotechnology company, discovers, develops and commercializes regenerative treatments that use naturally occurring cells to restore function in New Zealand. The company has a market capitalization of $ 10.37 million. The company's main product is NTCELL, a capsule with alginate coating, which is part of Phase IIb clinical trial for the treatment of Parkinson's disease. It currently has a negative result. It has a research collaboration agreement with the Center for Brain Research at the University of Auckland to identify additional neurodegenerative disease targets for clinical trials with NTCELL.

Avnet, Inc. (NASDAQ: AVT) Diagram of institutional positions


Source link

Pzena Investment Management increased its Avnet ring (AVT); LIVING CELL TECHNOLOGIES LTD ORDINARY SH (LVCLF) sellers reduced their shorts by 37.5%



<! –

Stock news

->

September 2, 2018 – From Ricky Cave

Avnet, Inc.'s logo (NASDAQ: AVT)

Pzena Investment Management Llc increased the participation of Avnet Inc (AVT) by 1.66% reported in 2018Q1 SEC filings. Pzena Investment Management Llc acquired 149,923 shares, while the share of Avnet Inc (AVT) decreased by 10.23%. Pzena Investment Management Llc has shares of 9.18 million with a value of $ 383.42 million, up from 9.03 million in the last quarter. Avnet Inc now has a value of $ 5.60 billion. The shares fell by 0.64% or $ 0.31 to $ 48.4 during the last trading session. Approximately 1.13 million shares traded or 18.40% higher than the average. Avnet, Inc. (NYSE: AVT) has increased by 4.99% since 2 September 2017 and is on the rise. It performed 7.5% less well than the S & P500. Some historical AVT news: 16/05/2018 – Avnet closes below 200-day moving average: Technicals; 30/05/2018 – Consolidated study: 2018 Summary Expectations for Crown Castle International, Avnet, computer programs & # 39; s, and Model N, Century; 14/05/2018 – Avnet shows connected ecosystem at IoT World 2018; 23/05/2018 – Avnet appoints Oleg Khaykin to his board of directors; 26/04/2018 – Avnet Inc 3Q Adj EPS $ 1.02; 26/04/2018 – Avnet Inc 3Q Loss / Shr $ 2.64; 24/04/2018 – Avnet Journal unveils keys for hardening the IoT-connected supply chain; 22/05/2018 – AVNET STATES REGULARLY QTRLY DIV $ 0.19 / SHR TO PAY JUNE 19; 17/04/2018 – Avnet closes above 50-day moving average: Technicals; 02/04/2018 – Avnet Inc. CDS broadens 8 Bps

LIVING CELL TECHNOLOGIES LTD ORDINARY SH (OTCMKTS: LVCLF) decreased by 37.5% in short-term interest rates. The SI of LVCLF amounted to 5,000 shares in September as released by FINRA. It fell by 37.5% compared to 8,000 shares. With 2,600 avg. Volume, 2 days are destined for the sellers of LIVING CELL TECHNOLOGIES LTD SHORT (OTCMKTS: LVCLF) live products to cover LVCLF short positions. The lock closed at $ 0.0194. It is 0.00% since 2 September 2017 and is. It performed less well with 12.57% of the S & P500.

Pzena Investment Management Llc reduced the importance of Cisco Systems Inc (NASDAQ: CSCO) with 144,324 shares to 2.72 million, valued at $ 116.86 million in 2018Q1. It also reduced the participation of Trimas Corp (NASDAQ: TRS) with 35,746 shares and now holds 2.32M shares. Chart Industries Inc is also reduced.

Of the 5 analysts who cover Avnet (NYSE: AVT), 2 have the ratings Buy, 2 Sell and 1 Hold. That is why 40% is positive. Avnet had 7 analyst reports since April 25, 2018 according to SRatingsIntel. On Friday, June 22, the share rating was tracked by Pivotal Research at "Buy". The company has given the rating "Neutral" on Wednesday, April 25 by Bank of America. Pivotal Research has Avnet, Inc. (NASDAQ: AVT) on Friday, June 15 upgraded to the & # 39; Buy & # 39 ;. The company has a & # 39; Sell & # 39; -rating from Goldman Sachs on Wednesday, May 16th. On the shares of Avnet, Inc. (NASDAQ: AVT) state & # 39; Sell ​​& # 39; -rating awarded by Citigroup on Thursday 9 August. Bank of America has upgraded the stock to "Buy" rating in the Friday August 10 report.

Another recent and important news from Avnet, Inc. (NASDAQ: AVT) was published by Seekingalpha.com, which published an article entitled "Avnet (AVT) Q4 2018 results – Earnings Call Transcript" on August 9, 2018.

Investor sentiment fell to 0.97 in Q1 2018. It decreased by 0.19, from 1.16 in 2017Q4. It declined, as 29 investors sold AVT shares while 115 had fewer holdings. 50 funds opened positions while 89 made higher bets. 113.40 million shares or 2.48% more of 110.65 million shares in 2017Q4 were reported. Bluemountain Cap Ltd Liability Corp has invested 0.15% in Avnet, Inc. (NASDAQ: AVT). Barrow Hanley Mewhinney and Strauss Limited Liability Corporation reported 0% of the portfolio in Avnet, Inc. (NASDAQ: AVT). Alpha Windward Limited Co. has purchased 0.33% or 12,857 shares. Bokf Na reported 13,752 shares. New York State Teachers Retirement Systems, a New York fund, reported 192,348 shares. Comerica Commercial Bank, a fund in Michigan, reported 349,418 shares. 865 are owned by Ledyard Bancshares. Ameritas Inv has 0.07% of its portfolio in Avnet, Inc. (NASDAQ: AVT) for 35,696 shares. Whittier Trust has invested 0% of its portfolio in Avnet, Inc. (NASDAQ: AVT). State Board of Administration of Florida Retirement Sys reported a 0.02% interest. New Mexico Educational Retirement Board reported 0.05% to Avnet, Inc. (NASDAQ: AVT). 550 are held by Meeder Asset Mgmt. Lpl Finance Ltd Llc has invested in 0% or in 7 886 shares. Brandywine Invest Mgmt reported 460,146 shares. Lombard Odier Asset (Switzerland) Sa owns 19,380 shares.

Living Cell Technologies Limited, a biotechnology company, discovers, develops and commercializes regenerative treatments that use naturally occurring cells to restore function in New Zealand. The company has a market capitalization of $ 10.37 million. The company's main product is NTCELL, a capsule with alginate coating, which is part of Phase IIb clinical trial for the treatment of Parkinson's disease. It currently has a negative result. It has a research collaboration agreement with the Center for Brain Research at the University of Auckland to identify additional neurodegenerative disease targets for clinical trials with NTCELL.

Avnet, Inc. (NASDAQ: AVT) Diagram of institutional positions


Source link

Leave a Reply